Fexuclue (fexuprazan) tablets for adults with acute or chronic gastritis — testing symptom improvement and safety.

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

In this observational, real-world study, adults prescribed Fexuclue (fexuprazan) will complete electronic patient-reported outcome (e-PRO) surveys on gastrointestinal symptoms before starting the medication and again 2 to 4 weeks after administration. A separate e-PRO will collect patient-reported convenience of the medication at about 2 weeks (up to 4 weeks). Investigators will also record their clinical judgment of overall improvement in the case report form (CRF). Eligibility is limited to adults aged 19–75 who are scheduled to receive Fexuclue according to approved indications, and no experimental procedures beyond routine care are imposed.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Adult subjects between the ages of 19 and 75 years at the time of obtaining written informed consent.
* Subjects who are scheduled to receive Fexuclu tablets (fexuprazan) in accordance with the approved indication.
* Subjects who present with at least one subjective symptom requiring medical treatment
* Subjects who are capable of understanding the information provided, have voluntarily decided to participate in this observational study, and have provided written informed consent for the use of their personal data.

Exclusion Criteria:

* Individuals who fall under any contraindications for the administration of Fexuclu tablets (fexuprazan) as specified in the approved labeling.
* Individuals who are deemed by the investigator (attending physician) to be inappropriate for participation in this observational study for any reason not otherwise specified.

Where it's running

• Masong Kim Internal Medicine Clinic
  Seoul, South Korea Recruiting

Study contacts

• Principal investigator: Jingun Kim, Dr. — Masong Kim Internal Medicine Clinic
• Study coordinator: So Heui Kim
• Email: 2210325@daewoong.co.kr
• Phone: 82-10-2994-5887

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Prevalence and possible role of non-H. pylori Helicobacter species in gastric conditions and cancers

  Researchers will test stomach tissue from people with functional dyspeasia, various gastritis conditions, gastric cancer, and bariatric patients to see if non-H. pylori Helicobacter species are present.

  Recruiting at 3 sites Universiteit Antwerpen · Edegem and 2 other locations · NCT07770126

• Adding Saccharomyces boulardii to bismuth quadruple therapy for H. pylori rescue

  This tests whether adding the probiotic Saccharomyces boulardii to bismuth-containing quadruple therapy helps adults whose H. pylori infection did not clear after prior treatments.

  Recruiting Phase 4 Xijing Hospital of Digestive Diseases · Xi'an, Shaanxi · NCT07139366

• Mobile capsule gastroscopy for detecting stomach problems in older and high-risk people

  This project will test if an AI-assisted swallowable camera (mobile capsule gastroscopy) can find stomach diseases in older adults and people at higher risk.

  Recruiting Nanfang Hospital, Southern Medical University · Guangzhou, Guangdong · NCT07032961

• How autoimmune atrophic gastritis develops and presents over time

  This project will follow adults with autoimmune atrophic gastritis to see how the disease progresses and affects the stomach, nutrient absorption, and overall health.

  Recruiting Fondazione IRCCS Policlinico San Matteo di Pavia · Pavia, Pavia · NCT07388459

• Investigating the link between atrophic gastritis and gastric cancer risk

  This study is trying to see if people with atrophic gastritis are more likely to develop gastric cancer, especially in areas where gastric cancer is common.

  Recruiting Shanghai Jiao Tong University School of Medicine · Shanghai, Shanghai Municipality · NCT06203327

• Registry and study on Helicobacter Pylori and related gastric conditions

  This study is trying to track how Helicobacter pylori infections affect the development of stomach problems, like pre-cancerous changes and cancer, in adults over time.

  Recruiting at 2 sites Chinese University of Hong Kong · Hong Kong and 1 other locations · NCT05053945

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.